- Severe recalcitrant nodular acne unresponsive to conventional therapy, including systemic antibiotics:
- PO 0.5-1mg/kg/day divided BD *15-20 weeks
- Capsule:
- 10mg
- 20mg
- Swallow with a full glass of water to reduce esophageal irritation
Retinoid
It inhibits sebaceous gland function and keratinization reducing sebum formation
- Nail disorder
- Skin disorder
- Pruritus
- Dry mucous membranes
- Epistaxis
- Anemia
- Back pain
- Arthralgia
- Myalgia
- Hypertriglyceridemia
- Conjunctivitis
- Increased LFTs
- Increased glucose
- Headache
- Neutropenia
- Photosensitivity
- Tinnitus
- Edema
- Fatigue
- Malaise
- Lymphadenopathy
- Weight loss
- Tachycardia
- Palpitations
- Gingival bleeding
- Nausea
- Arthritis
- Tendinitis
- Dizziness
- Insomnia
- Nervousness
- Paresthesia
- Weakness
- Hyperuricemia
- Abnormal menses
- Hypersensitivity to isotretinoin or vitamin A
- Pregnancy
- Breastfeeding during treatment and for at least 8 days after discontinuation
WARNING
NOT to be used in female patients who are or may become pregnant, because therapy poses an extremely high risk for severe birth effects (with any dose or duration)
None restricted
Drug Status
Availability | Prescription only |
Pregnancy | Category X |
Breastfeeding | Contraindicated |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
D’Acne | 10mg | Tablet | 30’s | Glenmark Pharma | Glenmark Pharma |
D’Acne | 20mg | Tablet | 30’s | Glenmark Pharma | Glenmark Pharma |
Isotrin | 10mg | Capsule | 30’s | Surgilinks Ltd C/O Stallion Labs | Surgilinks Ltd |
Isotrin | 20mg | Capsule | 30’s | Surgilinks Ltd C/O Stallion Labs | Surgilinks Ltd |
Roaccutane | 10mg | Capsule | 30’s | F. Hoffman-La Roche | Roche Kenya |
Roaccutane | 20mg | Capsule | 30’s | F. Hoffman-La Roche | Roche Kenya |